These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Once-Daily Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure in the Randomized Phase 3 MERCURY-2 Study. Walters TR; Ahmed IIK; Lewis RA; Usner DW; Lopez J; Kopczynski CC; Heah T; Ophthalmol Glaucoma; 2019; 2(5):280-289. PubMed ID: 32672669 [TBL] [Abstract][Full Text] [Related]
6. Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2). Serle JB; Katz LJ; McLaurin E; Heah T; Ramirez-Davis N; Usner DW; Novack GD; Kopczynski CC; Am J Ophthalmol; 2018 Feb; 186():116-127. PubMed ID: 29199013 [TBL] [Abstract][Full Text] [Related]
7. One Year of Netarsudil and Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Phase 3, Randomized MERCURY-1 Study. Brubaker JW; Teymoorian S; Lewis RA; Usner D; McKee HJ; Ramirez N; Kopczynski CC; Heah T Ophthalmol Glaucoma; 2020; 3(5):327-338. PubMed ID: 32768361 [TBL] [Abstract][Full Text] [Related]
8. Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial. Asrani S; Robin AL; Serle JB; Lewis RA; Usner DW; Kopczynski CC; Heah T; Am J Ophthalmol; 2019 Nov; 207():248-257. PubMed ID: 31229466 [TBL] [Abstract][Full Text] [Related]
9. Effects of Netarsudil on the Corneal Endothelium: Three-Month Findings from a Phase 3 Trial. Mundorf T; Mah F; Sheng H; Heah T Ophthalmol Glaucoma; 2020; 3(6):421-425. PubMed ID: 33250082 [TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty. Price MO; Price FW; Kruse FE; Bachmann BO; Tourtas T Cornea; 2014 Sep; 33(9):880-6. PubMed ID: 25062336 [TBL] [Abstract][Full Text] [Related]
11. Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension. Kopczynski CC; Heah T Drugs Today (Barc); 2018 Aug; 54(8):467-478. PubMed ID: 30209441 [TBL] [Abstract][Full Text] [Related]
12. Netarsudil Improves Trabecular Outflow Facility in Patients with Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 2 Study. Sit AJ; Gupta D; Kazemi A; McKee H; Challa P; Liu KC; Lopez J; Kopczynski C; Heah T Am J Ophthalmol; 2021 Jun; 226():262-269. PubMed ID: 33524367 [TBL] [Abstract][Full Text] [Related]
13. The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans. Kazemi A; McLaren JW; Kopczynski CC; Heah TG; Novack GD; Sit AJ J Ocul Pharmacol Ther; 2018 Jun; 34(5):380-386. PubMed ID: 29469601 [TBL] [Abstract][Full Text] [Related]
14. Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension. Araie M; Sugiyama K; Aso K; Kanemoto K; Kothapalli K; Kopczynski C; Senchyna M; Hollander DA Adv Ther; 2021 Apr; 38(4):1757-1775. PubMed ID: 33629227 [TBL] [Abstract][Full Text] [Related]
15. Effects of 0.02% netarsudil ophthalmic solution on intraocular pressure of normotensive dogs. Yang VY; Miller PE; Keys DA; La Croix NC Vet Ophthalmol; 2021 Mar; 24 Suppl 1():87-95. PubMed ID: 31908139 [TBL] [Abstract][Full Text] [Related]
16. Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy. Price MO; Price FW Am J Ophthalmol; 2021 Jul; 227():100-105. PubMed ID: 33737034 [TBL] [Abstract][Full Text] [Related]
17. Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2. Wisely CE; Sheng H; Heah T; Kim T Adv Ther; 2020 Mar; 37(3):1114-1123. PubMed ID: 31981106 [TBL] [Abstract][Full Text] [Related]
18. A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting. Zaman F; Gieser SC; Schwartz GF; Swan C; Williams JM Curr Med Res Opin; 2021 Jun; 37(6):1011-1020. PubMed ID: 33733980 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of topically administered netarsudil (Rhopressa™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG). Leary KA; Lin KT; Steibel JP; Harman CD; Komáromy AM Vet Ophthalmol; 2021 Mar; 24 Suppl 1(Suppl 1):75-86. PubMed ID: 31872953 [TBL] [Abstract][Full Text] [Related]
20. Prevention of corticosteroid-induced intraocular pressure elevation using ISV-205. Stewart WC; Arch Ophthalmol; 2003 Nov; 121(11):1543-7. PubMed ID: 14609909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]